Unknown

Dataset Information

0

Biallelic MUTYH mutations can mimic Lynch syndrome.


ABSTRACT: The hallmarks of Lynch syndrome (LS) include a positive family history of colorectal cancer (CRC), germline mutations in the DNA mismatch repair (MMR) genes, tumours with high microsatellite instability (MSI-H) and loss of MMR protein expression. However, in ?10-15% of clinically suspected LS cases, MMR mutation analyses cannot explain MSI-H and abnormal immunohistochemistry (IHC) results. The highly variable phenotype of MUTYH-associated polyposis (MAP) can overlap with the LS phenotype, but is inherited recessively. We analysed the MUTYH gene in 85 'unresolved' patients with tumours showing IHC MMR-deficiency without detectable germline mutation. Biallelic p.(Tyr179Cys) MUTYH germline mutations were found in one patient (frequency 1.18%) with CRC, urothelial carcinoma and a sebaceous gland carcinoma. LS was suspected due to a positive family history of CRC and because of MSI-H and MSH2-MSH6 deficiency on IHC in the sebaceous gland carcinoma. Sequencing of this tumour revealed two somatic MSH2 mutations, thus explaining MSI-H and IHC results, and mimicking LS-like histopathology. This is the first report of two somatic MSH2 mutations leading to an MSI-H tumour lacking MSH2-MSH6 protein expression in a patient with MAP. In addition to typical transversion mutations in KRAS and APC, MAP can also induce tumourigenesis via the MSI-pathway.

SUBMITTER: Morak M 

PROVIDER: S-EPMC4200426 | biostudies-literature | 2014 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Biallelic MUTYH mutations can mimic Lynch syndrome.

Morak Monika M   Heidenreich Barbara B   Keller Gisela G   Hampel Heather H   Laner Andreas A   de la Chapelle Albert A   Holinski-Feder Elke E  

European journal of human genetics : EJHG 20140212 11


The hallmarks of Lynch syndrome (LS) include a positive family history of colorectal cancer (CRC), germline mutations in the DNA mismatch repair (MMR) genes, tumours with high microsatellite instability (MSI-H) and loss of MMR protein expression. However, in ∼10-15% of clinically suspected LS cases, MMR mutation analyses cannot explain MSI-H and abnormal immunohistochemistry (IHC) results. The highly variable phenotype of MUTYH-associated polyposis (MAP) can overlap with the LS phenotype, but is  ...[more]

Similar Datasets

| S-EPMC5094810 | biostudies-literature
| S-EPMC7526538 | biostudies-literature
| S-EPMC5558182 | biostudies-literature
| S-EPMC5065659 | biostudies-literature
| S-EPMC5995637 | biostudies-literature
| S-EPMC5374027 | biostudies-literature
| S-EPMC2538673 | biostudies-literature
| S-EPMC9060067 | biostudies-literature
| S-EPMC9170691 | biostudies-literature
| S-EPMC2759321 | biostudies-literature